FMP
XOMA Corporation
XOMA
NASDAQ
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
20.19 USD
1.43 (7.08%)
XOMA Financial Statements
Year
2024
2023
2022
2021
Total Revenue
28.49M
4.76M
6.03M
38.16M
Cost of Revenue
206k
897k
97k
171k
Gross Profit
28.28M
3.86M
5.93M
37.99M
Operating Expenses
68.26M
46.46M
23.44M
20.63M
Research and Development
2.88M
143k
153k
171k
Selling, General & Administrative Expenses
34.48M
25.61M
23.19M
20.46M
Selling & Marketing Expenses
0
0
0
0
General & Administrative Expenses
34.48M
25.61M
23.19M
20.46M
Other Expenses
30.9M
20.71M
97k
-879k
Operating Income
-39.98M
-41.85M
-17.41M
17.53M
Total Other Income/Expenses Net
20.5M
1.02M
295k
-1.64M
Income Before Tax
-19.48M
-40.83M
-17.12M
15.89M
Income Tax
-5.66M
0
-15k
91k
Net Income
-13.82M
-40.83M
-17.1M
15.8M
Basic EPS
-0.71
-4.04
-1.5
1.4
EPS Diluted
-0.71
-4.04
-1.5
1.3
Basic Average Shares
11.7M
11.47M
11.41M
11.29M
Diluted Average Shares
11.7M
11.47M
11.41M
12.19M
EBITDA
-5.42M
-39.36M
-16.84M
16.52M
Retained Earning Schedule
Year
2024
2023
2022
2021
Retained Earnings (Previous Year)
-1.22B
-1.18B
-1.17B
-1.18B
Net Income
-13.82M
-40.83M
-17.1M
15.8M
Stock Repurchases
-13k
-148k
-1.4M
-488k
Dividend Paid
-5.47M
-5.47M
-5.47M
-3.5M
Retained Earnings
-1.24B
-1.22B
-1.18B
-1.17B
Other Distributions
-19.32M
-46.45M
-23.97M
11.81M
PPE Schedule
Year
2024
2023
2022
2021
Gross PPE
351k
403k
36k
213k
Annual Depreciation
216k
900k
274k
167k
Capital Expenditure
-20k
-17k
-23.25M
-26.5M
Net PPE
155k
-480k
23.01M
26.55M
Intangible and Goodwill Schedule
Year
2024
2023
2022
2021
Acquisitions and Adjustments
0
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
0
0
0
0
All figures are in USD.
